Allogeneic Stem Cell Transplantation With 3-days Busulfan Plus Fludarabine as Conditioning in Patients With Relapsed or Refractory T-, NK/T-cell Lymphomas
Phase of Trial: Phase II
Latest Information Update: 06 Feb 2017
At a glance
- Drugs Busulfan (Primary) ; Fludarabine (Primary)
- Indications Peripheral T-cell lymphoma; T cell lymphoma
- Focus Therapeutic Use
- Acronyms RRTCLAlloSCT
- 31 Jan 2017 Planned End Date changed from 1 Sep 2021 to 1 Dec 2021.
- 31 Jan 2017 Planned primary completion date changed from 1 Sep 2019 to 1 Dec 2019.
- 31 Jan 2017 Status changed from not yet recruiting to recruiting.